All-trans-retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia.
Degos
L
L
Service Clinique des Maladies du Sang, Hôpital St Louis, Paris, France.
Dombret
H
H
Chomienne
C
C
Daniel
M T
MT
Micléa
J M
JM
Chastang
C
C
Castaigne
S
S
Fenaux
P
P
D000971:Antineoplastic Combined Chemotherapy Protocols; D001778:Blood Coagulation Disorders / Q000139:chemically induced; D016026:Bone Marrow Transplantation; D002454:Cell Differentiation / Q000187:drug effects; D004351:Drug Resistance; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000188:drug therapy*; D018365:Neoplasm, Residual / Q000175:diagnosis; D016019:Survival Analysis; D013927:Thrombosis / Q000139:chemically induced; D014212:Tretinoin / Q000009:adverse effects / Q000627:therapeutic use*
D014212:Tretinoin